LRMR

Larimar Therapeutics Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↓ 2/10
  • Value↓ 4/10
Larimar Therapeutics sales and earnings growth
LRMR Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -40.00%
  • FCF Y/Y↓ -50.16%
Larimar Therapeutics gross and profit margin trends
LRMR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -117.52%
Larimar Therapeutics net debt vs free cash flow
LRMR Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Larimar Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks